Janus Henderson Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Hold |
12,179
| – | – | ﹤0.01% | 2123 |
|
|
2025
Q1 | $281K | Hold |
12,179
| – | – | ﹤0.01% | 2231 |
|
|
2024
Q4 | $241K | Hold |
12,179
| – | – | ﹤0.01% | 2353 |
|
|
2024
Q3 | $304K | Hold |
12,179
| – | – | ﹤0.01% | 2266 |
|
|
2024
Q2 | $228K | Sell |
12,179
-180
| -1% | -$3.36K | ﹤0.01% | 2348 |
|
|
2024
Q1 | $244K | Buy |
12,359
+6
| +0% | +$118 | ﹤0.01% | 2331 |
|
|
2023
Q4 | $217K | Sell |
12,353
-26
| -0.2% | -$456 | ﹤0.01% | 2406 |
|
|
2023
Q3 | $215K | Buy |
12,379
+3
| +0% | +$52 | ﹤0.01% | 2344 |
|
|
2023
Q2 | $174K | Hold |
12,376
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q1 | $133K | Buy |
+12,376
| New | +$133K | ﹤0.01% | 2580 |
|
|
2021
Q3 | – | Sell |
-1,096,252
| Closed | -$15.3M | – | 2212 |
|
|
2021
Q2 | $15.3M | Sell |
1,096,252
-30,650
| -3% | -$427K | 0.01% | 852 |
|
|
2021
Q1 | $20.9M | Sell |
1,126,902
-6,046
| -0.5% | -$112K | 0.01% | 761 |
|
|
2020
Q4 | $20M | Buy |
1,132,948
+14,687
| +1% | +$260K | 0.01% | 750 |
|
|
2020
Q3 | $17.1M | Buy |
+1,118,261
| New | +$17.1M | 0.01% | 741 |
|